A sugar-pathway molecule just showed up as an inflammaging brake.

Nature Aging — Song / Hu / Li: phosphoenolpyruvate (PEP), a glycolytic metabolite, as an endogenous cGAS inhibitor.

What's new:
🟢 mice + humans: PEP rises early in aging, then falls — a biphasic “protect then fade” curve
🟢 block PEP buildup → more inflammation, faster aging traits
🟢 give PEP before the decline → healthier aging in mice
🟢 aged humans with higher PEP → lower inflammation + healthier traits
🟣 mechanism: PEP competitively binds cGAS → dials down cGAS–STING
🟢 AD mice: less neuroinflammation, better cognition

Caveats:
🟠 mice intervention + human correlation — not a human PEP pill trial
🟠 timing matters: benefit shown before the late decline window
🟠 don’t confuse this with “more sugar = longevity”

🗒 Inflammaging isn’t only cytokines. A metabolite can sit on the cGAS switch.

DNA context for the habits you keep stacking → TellMeGen

Source: Song et al., Nature Aging 2026 · DOI 10.1038/s43587-026-01087-1

Your brain has a second proteome — and Alzheimer’s rearranges it.

Nature Aging (14 Sep 2026) — Salk / Miller + Saghatelian: first microprotein atlas of the human frontal cortex (AD vs non-AD).

What's new:
🟢 >600 postmortem cortices → transcriptomics + mass spec + deep-learning spectra
🟢 1,067 microproteins (≤150 aa) missing from reviewed UniProt — high-confidence spectral support
🟢 a subset shifts in AD independently of the main ORF at the same locus
🟣 Micro-MKKS63 (63 aa at the MKKS locus): the predominant translation product there, downregulated in AD
🟣 knock it out in microglia → mitochondrial respiration collapses

Caveats:
🟠 atlas + mechanism clue — not a drug
🟠 postmortem human tissue; Micro-MKKS63 is one hit among >1,000
🟠 “new proteins” ≠ instant targets — validation still ahead

🗒 Aging and neurodegeneration may have been missing a whole protein class. Microproteins just joined the map.

Source: Miller et al., Nature Aging 2026 · DOI 10.1038/s43587-026-01207-x

Aging clocks were mostly sex-blind — Nature Medicine just built 38 that aren’t.

Nature Medicine (16 Sep 2026) — Song / Feng et al.: 38 sex-specific aging clocks across 15 organ systems (AI age − chronological age).

What's new:
🟢 prior clocks mostly sex-pooled, assuming sex invariance
🟢 sex-stratified training → marked ♀ vs ♂ divergence
🟢 genetics + MR: organ aging + cardiometabolic / endocrine / mental links differ by sex
🟣 proteomics: distinct organ-resolved synaptic, immune, vascular, metabolic networks for ♀ vs ♂
🟢 predict disease + mortality in sex- and organ-dependent ways
🟣 brain clock: sex-dependent cognitive-decline link in a preclinical AD trial

Caveats:
🟠 sex-pooled still useful — also build sex-stratified references
🟠 clocks ≠ clinic-ready sex-specific panel tonight

🗒 One birthday, many organs — the map differs for women and men.

AgePilot — habits that move the healthspan dial → t.me/AgePilotBot

Source: Song et al., Nat Med 2026 · DOI 10.1038/s41591-026-04662-6

Your DNA-repair alarm can get stuck ON — LSD1 holds the switch.

JCI (15 Sep 2026) — Mayo Clinic / Zhang + Li: LSD1 demethylates ATM at K3016 and prolongs the damage response.

What's new:
🟢 LSD1 protein ↑ in aged organs + senescent cells (mRNA flat — stability, not transcription)
🟢 demethylates ATM-K3016 → sustains p-ATM, delays WIP1 recovery → senescence
🟢 ORY-1001 (LSD1i): less senescence/SASP in IR + natural aging; less fibrosis
🟣 protects against irradiation-induced hair graying
🟢 senolytics cut LSD1 too — feedback loop with zombie cells
🟣 LSD1 cleared by autophagy (LC3/Beclin1); aging autophagy fail → LSD1 piles up

Caveats:
🟠 mice + cells — not a human longevity trial
🟠 ORY-1001 is oncology-leaning — don't DIY epigenetics

🗒 Persistent DDR isn't just leftover damage — epigenetic brakes on ATM recovery matter.

Source: Zhang et al., JCI 2026 · DOI 10.1172/JCI199854

Your organs don’t age on one schedule — PathStAR maps the structural timeline.

Nature Aging — Yadav / Sinha et al.: PathStAR scores tissue structural aging from routine histopathology — not trained to guess chronological age.

What's new:
🟢 25,306 biopsies · 40 tissues · 970 donors (21–70)
🟢 vessels accelerate early; uterus/vagina late (~menopause); digestive + male reproductive show biphasic spikes
🟢 accelerations: ↑ inflammation, ↓ energy / repair / quality control
🟣 within people, some organs sync — digestive ↔ male reproductive, linked to sex hormones

Caveats:
🟠 post-mortem slides — not a wearable organ-age app
🟠 structural score ≠ proven mortality clock
🟠 atlas of deterioration, not a therapy

🗒 Aging is a network of tissue geometries — not one birthday.

DNA aging risk check → TellMeGen

Source: Yadav et al., Nat Aging 2026 · DOI 10.1038/s43587-026-01200-4

Frontier AI just sat an aging-biology exam — compact specialists beat the giants.

Cell (17 Sep 2026) — Zhavoronkov / Gladyshev / Galkin: LongevityBench — 17 tasks · 5 biodata domains — plus open Longevity-LLMs and Longevity Claw.

What's new:
🟢 clinical · epigenomics · transcriptomics · proteomics · genetics
🟢 18 frontier systems from 6 labs — no single model wins everything
🟢 hardest: omics age prediction (scale alone doesn't fix it)
🟣 compact Longevity-LLMs (0.6B–9B) match or beat far larger frontier models
🟣 DNAm pairwise: L-Qwen3.5-9B concordance 0.868 vs ~0.685 best frontier
🟣 proteomic age MAE ~5.7 y (0.6B) vs ~10.1 y best frontier

Caveats:
🟠 company-led toolkit — useful, not a clinical AI product
🟠 benchmark score ≠ a therapy or longevity coach tonight
🟠 open release ≠ medical advice

🗒 Aging AI needs graded tests on real omics — not vibes. Domain-tuned small models can outscore the frontier here.

Source: Zhavoronkov et al., Cell 2026 · DOI 10.1016/j.cell.2026.08.026

An FDA ataxia drug just crowbarred STING into the trash — and cooled aging inflammation in mice.

Nature Communications (17 Sep 2026): screen hit = omaveloxolone (Skyclarys®) — approved for Friedreich’s ataxia — as a STING degrader, not only an NRF2 booster.

What's new:
🟢 DC₅₀ ≈ 118 nM · Dₘₐₓ ≈ 98.6% STING clearance
🟢 binds STING LBD (KD ≈ 21.4 nM) → “molecular crowbar”: blocks LBD closure, destabilizes the fold
🟢 HUWE1 → K27-Ub at K236/K347/K370 → proteasome
🟢 aged ♂ mice: STING↓, inflammatory signaling quieter, aging-inflammation phenotypes ease
🟣 NRF2 activation is independent — dual dial (inflammation + antioxidant)

Caveats:
🟠 mice (aged males) + cells — not a human longevity trial
🟠 in-vivo benefit may mix STING loss + NRF2; don’t DIY ataxia dosing for aging

🗒 Inflammaging’s DNA-sensing arm may be drug-reachable via conformational trash-tagging.

AgePilot — habits that move the healthspan dial → t.me/AgePilotBot

Source: Nat Commun 2026 · DOI 10.1038/s41467-026-77760-1

Why are so many of the world’s richest people old?

Altrata Billionaire Census 2026: average billionaire age is 71. Almost half are over 70. Only ~9% are under 50.

Young founder stories make the news. The real pyramid is older.

Two simple reasons:
🟢 Money takes time. Big fortunes grow over decades — companies, stock, compounding. Most built their wealth (~62%). Only ~8% fully inherited it.
🟢 Money also buys more years. NEJM (US + Europe, 50–85): the richest had ~40% lower risk of dying than the poorest (adjusted). Better care, less stress, safer life.

So the top isn’t “forever young founders.” It’s aging builders + aging capital. Next decade: about $6.6 trillion to ~5,000 heirs.

Longevity punchline: more years to get rich often means more years alive. That gap is the story.

Altrata Billionaire Census 2026

CIS 100+: who actually counts the oldest?

Different years and agencies — not one clean ranking.

🟢 Russia 37,235 · 1 Jan 2022 · Rosstat
🟢 Kyrgyzstan 1,698 · early 2022 · NatStat
🟢 Azerbaijan 1,310 · 1 Jan 2024 · State Stat.
🟢 Belarus 613 · Sep 2024 · MinLabor
🟢 Uzbekistan 514 · 1 Jan 2024 · Pension Fund
🟢 Kazakhstan 448 · ~Sep 2025 · MinLabor
🟣 Tajikistan 306 · 1 Jan 2025 · 169♂ / 137♀

🇯🇵 Japan for scale: ~99,763 people 100+ (1 Sep 2025 · MHLW). Not magic food — a stack:
• plant-forward eating + hara hachi bu (~80% full)
• daily movement (walking, gardening, daily life)
• ikigai — a reason to get up
• close circle (moai) for decades
• low smoking + accessible care

🟠 Steal Japan’s habits: move + strength, sleep, BP, close people, don’t smoke.

🗒 Check year, agency, definition first.

Genetic markers? TellMeGen

Senescent cells don’t just stop dividing — their whole protein house falls out of sync.

Nature Communications (16 Sep 2026) — Da Silva Fernandes / Beli lab: a time-lapse proteome of human cells hitting replicative senescence.

What's new:
🟢 chromatin proteins drain away (histones hang on longer)
🟢 the translation machinery thins out
🟢 mitochondrial proteins clump / turn insoluble
🟢 autophagy + proteasome get sluggish — even when some “cleanup” proteins rise
🟣 a senescence-specific proteostasis fingerprint

Caveats:
🟠 dish fibroblasts, not people
🟠 a map, not a drug

🗒 Aging zombies aren’t only DNA-scarred — their protein logistics fail in a coordinated wave.

Source: Nat Commun 2026 · DOI 10.1038/s41467-026-77686-8

Aging bone marrow gets a bad order from T cells: make more neutrophils.

Nature Aging (26 Aug 2026; briefing 18 Sep) — Gabandé-Rodríguez / Soto-Heredero: cytotoxic CD4⁺ T cells drive age-related myeloid skewing.

What's new:
🟢 CD4⁺ CTLs pile up in aged bone marrow
🟢 they push myelopoiesis → higher neutrophil-to-lymphocyte ratio (NLR)
🟢 TCR → mitochondrial stress → STING → chemokine CCL5
🟢 aged HSCs / myeloid progenitors upregulate CCR5
🟢 FDA CCR5 blocker maraviroc (1 month in old mice): myelopoiesis rebalanced, fewer tissue neutrophils, better aging biomarkers + function

Caveats:
🟠 mice — not a human longevity trial
🟠 HIV drug — don’t DIY “anti-aging” dosing

🗒 Inflammaging can start as a T-cell → stem-cell signal. Mute CCL5–CCR5, and the marrow cools.

AgePilot — habits that move the healthspan dial → t.me/AgePilotBot

Source: Gabandé-Rodríguez et al., Nat Aging 2026 · DOI 10.1038/s43587-026-01209-9

Four mammals. 11,000+ gene-activity maps. One shared “death signature.”

Nature (Tyshkovskiy / Gladyshev): shared transcriptomic hallmarks of ageing and mortality — mouse, rat, macaque, human · 25+ tissues.

What's new:
🟢 age + mortality clocks: interventions, time-to-death, disease, rejuvenation
🟢 standouts: CDKN1A (p21) + LGALS3 — plasma proteins also link to death risk and many diseases at once (UK Biobank)
🟢 modular clocks: inflammation · interferon · mitochondria · chromatin · tissue matrix (ECM)
🟣 diseases mostly speed up the inflammatory module; calorie restriction / Klotho hit mito–metabolic ones
🟣 signature rises with damage (senescence, γ-irradiation…) and falls with reprogramming, shared-blood setups (parabiosis), early embryo stages

Caveats:
🟠 transcriptomic clocks ≠ a proven longevity therapy
🟠 a map of subsystems to score — not a pill

🗒 Ageing isn’t one dial — it’s modules you can read separately.

One cigarette ≈ 20 minutes of life. Smoking also ages your bio clock by ~9 years.

Not a slogan — averages from new papers:
🟢 ~20 min of life expectancy per cigarette on average (Addiction 2025; older figure was ~11 min)
🟢 On a methylation clock (GrimAge2), current smokers looked ~9.1 years older than never-smokers; former smokers still ~2.8 years older (NHANES adults 50+)
🟢 Quit and stay quit: under 3 years off ≈ ~5 years of life kept; 10+ years off ≈ ~10 years (NEJM Evidence 2024)

Vapes are not a free pass. A 2026 cardiology review: no nicotine product is safe for the heart. Dual use (cigarette + vape) often looks worst for vessel risk.

Secondhand smoke still kills at scale: ~1.66 million deaths / year in the latest GBD read (Lancet Public Health 2026).

🗒 These are population averages and associations — not a stopwatch for one puff. Still: less smoke = more years you can measure.

Why the H₂ flask ad doesn’t prove a bio-age rewind

Echo Flask–class bottles sell a screen and “ppm magic.” Here’s what science actually shows:

🟢 Physics: dissolved H₂ leaves water fast (like soda). Open-cup half-life ~2 h (Molecular Hydrogen Institute). A peak ppm on the display ≠ the dose hours later.
🟢 Review: IJMS 2024 systematic review (25 papers) — signals are preliminary; authors call for bigger, stricter trials before health claims.
🟢 Best aging pilot: Exp Gerontol 2021 · n=40 · 70+ · 6 months (NCT04430803). Many biomarkers tested; most showed no clear between-group effect. A couple of shifts ≠ “years younger.”
🟢 Ads skip the hard endpoint: no large trial proving lower mortality or a validated epigenetic-clock reset.

🟠 Ritual water is fine. Paying ~€300 for immortality marketing isn’t science.

Better odds tonight: sleep, walk, food, no smoke.

People argue about protein powders. Almost nobody argues about the muscle that keeps you walking at 80.

At a Metaphase talk, physiologist Daniil Popov put it bluntly: guard your thigh muscles.

Why thighs matter more than abs:
🟢 they are a huge metabolic organ, not just decoration
🟢 they help keep insulin working
🟢 lose them, and frailty arrives early

You do not need a fancy protocol.
Walk most days. Sit-to-stand and light squats twice a week. Eat enough protein.

CONCLUSION: if you only train one thing for longevity, train the legs that carry you.

What’s one leg move you actually do this week?

Past 100, a rare killer T cell quietly takes over the blood.

Cell Reports (Hashimoto / Osaka): CD4 cytotoxic T cells — hybrids that both spot and kill — expand in Japanese centenarians and supercentenarians, and they don’t look exhausted.

What's new:
🟢 share of circulating T cells (medians): ~4% at 70–99 → ~9.6% at 100–109 → ~17.6% at 110+
🟢 the jump starts around age 100
🟢 huge clones (top clones ~33% on average) — repeated antigen hits over years
🟢 their receptors match tumor-expanded T cells (esp. lung cancer) — donors had no cancer history
🟣 same clone can flex Th1 / Th2 / Tfh-like cytokines ex vivo

Caveats:
🟠 blood snapshot — does not prove these cells cause longevity
🟠 Japan cohort; what they do in tissues is still open

🗒 Extreme aging may rewire immunity — not only wear it out.

DNA aging risk check → TellMeGen

Lose one mTORC2 brake — and worms suddenly “hear” their bacteria’s B12.

Nature Communications (Motwani / Mukhopadhyay, 14 Sep 2026): worm RICTOR (rict-1) normally restrains how hard the host reacts to microbe-supplied vitamin B12 + methionine.

What's new:
🟢 lose rict-1 → longer life + stronger osmotic stress tolerance — but only on B12-rich diets (HT115, or OP50 + B12)
🟢 needs host methionine cycle (METR-1) and B12-dependent MMCM-1 → more succinate
🟢 succinate fragments mitochondria → PINK-1/PDR-1 mitophagy = the longevity switch
🟣 early-life fragmentation keeps mitophagy high into late adulthood; wild-type mitochondria fade
🟢 bacterial Met-cycle genes matter too — true host–microbe crosstalk

Caveats:
🟠 C. elegans — not a human “block RICTOR” recipe
🟠 mammalian RICTOR biology is context-heavy; don’t DIY mTORC2 drugs for aging

🗒 Longevity here is diet-tuned organelle cleanup — gated by a gut micronutrient.

DNA aging risk check → TellMeGen

Your aging heart may lose its drainage pipes — then inflammation piles up.

Nature Cardiovascular Research (Wagner / Dimmeler): aging thins the heart’s lymphatics — vessels that clear fluid and waste — in mice and humans.

What's new:
🟢 aged hearts: fewer LYVE1+ lymphatics + tighter “zipper” junctions
🟢 then macrophages, fibrinogen, amyloid, edema — diastolic stress rises (systole more preserved)
🟢 nuclear IL-33 ↑ in lymphatic endothelium → cell death + junction remodeling
🟣 VEGFC falls with age and normally holds IL-33 down
🟢 Vegfc boost or Il33 silencing rebuilds lymphatic density and cools tissue inflammation in old mice

Caveats:
🟠 mouse genetics / AAV — not a human “VEGF-C for aging hearts” trial
🟠 VEGFC rebuilt lymphatics and cut macrophages but did not clearly fix diastolic function
🟠 human data mainly confirm density loss — therapy still open

🗒 Cardiac inflammaging may start as a drainage failure — not only “angry blood vessels.”

Your cell “power plants” may age when a key fat building block runs low.

Nature Communications (Poliezhaieva / Ermolaeva): with age, making phosphatidylcholine (PC) — a fat that builds membranes — can drop. Mitochondria (the cell’s power plants) then break into weaker pieces.

What's new:
🟢 In worms and human data, PC making falls with age → mito networks look older and broken
🟢 Giving PC or choline later helped rebuild those networks; human cells handled stress better
🟣 In people, the PC drop looked strongest in women around menopause

Caveats:
🟠 Worms + cells — not a human pill trial for longer life
🟠 Store choline/PC ≠ proven anti-aging here

🗒 Mito aging may partly be a supply problem — not only DNA wear.

AgePilot — habits that move healthier years → t.me/AgePilotBot

Your body has a sleep “sweet spot” — and sleeping more is not always better.

Big UK data linked how long people sleep with dozens of “body age” signals (heart, liver, blood, and more).

🟢 too little sleep (under 6 hours) — the body looked older
🟢 too much sleep (over 8 hours) — same problem
🟢 the calmer zone sat around about 6.5–8 hours for most people

This is a pattern, not a magic rule. Illness can also make people sleep longer.

CONCLUSION: protect the middle. Same bedtime most nights beats “I’ll catch up on Sunday.”

How many hours do you actually get most nights?

https://www.nature.com/articles/s41586-026-10524-5

Ozempic can lower the number on the scale. New body scans say it may also take more muscle than you expect.

Researchers compared people who started a GLP-1 shot with similar people who did not. They used full-body MRI years apart.

🟢 starters lost noticeably more muscle volume
🟢 roughly 60% more muscle loss than the comparison group
🟢 weight went down too — so “thinner” is not the whole story

This is early data, not the final word. But the practical lesson is clear.

CONCLUSION: if you use these shots, lift something and eat enough protein. Longevity needs muscle, not just a smaller waist.

Want a simple baseline before you chase any drug story? AgePilot:
https://t.me/AgePilotBot?start=ref_134163805

Would you track muscle, not just kilos?

https://www.medrxiv.org/content/10.64898/2026.09.15.26363157v1